Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026?
One-OffHealth & Medicine3moisFutuurDonnées de résolution vérifiéesProbabilité implicite actuelleNon 93%
Qualité du marché
31 / 100
Faible qualitéVolume 24h
—
Liquidité
308,4 €
Faible liquiditéTraders
8
Commentaires
0
Données du marché
Mis à jour il y a 1 minute
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will artificial blood be used to treat a patient by the end of 2026?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurWill artificial blood be used to treat a patient by the end of 2027?
Manifold MarketsHow many patients will be treated under right-to-try in Montana within 2026?
FutuurPeer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
Manifold MarketsWill Artificial wombs for premature babies be tested in humans by the end of 2026?
FutuurRègles
Les critères de résolution ne sont pas encore disponibles pour ce marché. Cette section sera remplie lors des prochains rafraîchissements une fois les règles de la source enregistrées.
Marchés ouverts
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 18,3 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- 1,6 M €
- Volume 24h
- 5,2 k €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 résultats de plus
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- 916 k €
- Volume 24h
- 1,5 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 résultats de plus
- Volume total
- 863,6 k €
- Volume 24h
- 1 k €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? ?
- Futuur cote No à 93% au 8 septembre 2026.
- Quand Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? sera-t-il résolu ?
- Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026? doit être résolu le 31 décembre 2026.